Jan 19 2026HEALTH
Why Big Pharma Stocks Might Be the Next Big Thing
Healthcare leaders gathered in San Francisco for a major industry event. This conference, known for its massive turnout and high-energy atmosphere, brought together CEOs from big and small drug companies. The buzz was around GLP-1 drugs, which have transformed diabetes and obesity treatment and are
reading time less than a minute
